Flag Ship Acquisition Shareholders Elect Directors, Approve Pay and Auditor

Key Points

• Shareholders elected three Class II directors—McAndrew Rudisill, Ryan Smith and Jason New—to serve until the 2028 annual meeting.
• Shareholders approved the advisory vote on named executive officer compensation and ratified M&K CPAs, PLLC as the independent auditor for fiscal 2026.
• The virtual meeting established a quorum with 68.5% of voting power represented; polls were open for about one minute before the meeting was adjourned.

Forum Markets Incorporated held its 2026 annual meeting of stockholders virtually on Aug. 19, with shareholders electing three Class II directors, approving an advisory vote on executive compensation and ratifying the company’s independent accounting firm.

John Saunders, the company’s Chief Financial Officer, Vice President of Finance and Secretary, opened the meeting at 10:00 a.m. Eastern Time. Saunders said the virtual format enabled the company to reach a greater number of stockholders. Shareholders of record as of June 24, 2026, who had registered for the meeting were permitted to submit questions through the meeting web portal.

McAndrew Rudisill, Forum Markets’ Chairman and Chief Executive Officer, chaired the meeting and introduced the company’s directors and other attendees. Rudisill said Anthony Carradio of Broadridge Financial Solutions had taken an oath to serve as Inspector of Elections.

Quorum Established

The Inspector of Elections reported that 68.5% of the voting power of Forum Markets’ outstanding common stock entitled to vote was represented in person or by proxy. The company therefore established a quorum and proceeded with the business of the meeting.

Rudisill said Broadridge Financial Solutions had provided an affidavit confirming that notice of the meeting was properly delivered to shareholders of record. The company said copies of the notice and affidavit would be incorporated into the meeting minutes.

Director Elections and Other Proposals

Shareholders considered three proposals:

• The election of three Class II directors to serve until the 2028 annual meeting of stockholders and until their successors are elected and qualified, unless they resign or are removed earlier.
• An advisory, non-binding vote on the compensation of the company’s named executive officers, as disclosed in the proxy statement.
• Ratification of M&K CPAs, PLLC as the company’s independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.

Rudisill said Forum Markets did not receive shareholder nominations for director candidates before the deadline specified in its bylaws. He also said the company did not receive any shareholder proposals or other business for consideration at the meeting.

While shareholder approval was not required for the auditor appointment, Rudisill said the board submitted the matter for a vote as a matter of good corporate practice.

Preliminary Results

Voting polls opened at 10:05 a.m. Eastern Time and closed at 10:06 a.m. Eastern Time. Based on the preliminary report from the Inspector of Elections, McAndrew Rudisill, Ryan Smith and Jason New were elected as Class II directors.

Shareholders also approved the advisory proposal concerning named executive officer compensation and approved the ratification of M&K CPAs, PLLC as the company’s independent registered public accounting firm for 2026.

With no further business presented, the meeting was adjourned.

About Flag Ship Acquisition (NASDAQ:ETHZ)

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source